Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-08-25

Clinical Trial Update: Ablation of Clinical Ventricular Tachycardia Versus Addition of Substrate Ablation on the Long Term Success Rate of VT Ablation [Phase 3]

View source ↗

Summary

A Phase 3 trial compared ablation of clinical ventricular tachycardia alone versus adding substrate ablation, assessing long-term success of VT ablation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Texas Cardiac Arrhythmia Research Foundation | Conditions: Ventricular Tachycardia | Phase 3 | Status: COMPLETED